首页> 外国专利> COMPOSITION COMPRISING CURCUMIN-CAPTURED GINSENOSIDE AND PHOSPHOLIPID-BASED LIPID NANOPARTICLE AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING HELICOBACTERPYLORI INFECTION

COMPOSITION COMPRISING CURCUMIN-CAPTURED GINSENOSIDE AND PHOSPHOLIPID-BASED LIPID NANOPARTICLE AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING HELICOBACTERPYLORI INFECTION

机译：包含姜黄素捕获的人参皂苷和磷脂基脂质的组合物，是预防或治疗幽门螺杆菌 幽门螺杆菌感染的有效成分

展开▼

页面导航

摘要

著录项

相似文献

摘要

The present invention relates to a composition comprising curcumin-captured ginsenoside and phospholipid-based lipid nanoparticles as an effective ingredient for preventing or treating Helicobacterpylori infection. More particularly, curcumin-captured ginsenoside and phospholipid-based lipid nanoparticles of the present invention improve solubility and stability of the captured curcumin and have excellent antibacterial activity against Helicobacterpylori, thus finding useful applications in the treatment of Helicobacterpylori infection. 展开▼

机译：本发明涉及一种组合物，其包含姜黄素捕获的人参皂苷和磷脂基脂质纳米颗粒作为预防或治疗幽门螺杆菌感染的有效成分。更特别地，本发明的姜黄素捕获的人参皂苷和磷脂基脂质纳米颗粒改善了捕获的姜黄素的溶解性和稳定性，并且对幽门螺杆菌幽门螺旋杆菌具有优异的抗菌活性，因此发现在幽门螺杆菌 幽门螺旋杆菌感染的治疗中有用的应用。 展开▼

著录项

公开/公告号WO2018135912A3

专利类型

公开/公告日2019-01-24

原文格式PDF

申请/专利权人 GACHON UNIVERSITY OF INDUSTRY-ACADEMIC COOPERATION FOUNDATION;
展开▼

申请/专利号WO2018KR00936

发明设计人 YOO BONG KYU;AJAY VIJAYAKUMAR;JEONG KWANG WON;CHUNG JUNWON;
展开▼

申请日2018-01-22

分类号A61K9/51;A61K31/12;A61K47/24;A23L33/10;

国家 WO

入库时间 2022-08-21 11:58:12

相似文献

专利

外文文献

中文文献

1. 用于预防或治疗幽门螺杆菌感染的包含忍冬花水提取物的药物组合物 [P] . 中国专利： CN113423415A . 2021-09-21

2. 用于治疗、改善和预防幽门螺杆菌感染的组合物和方法 [P] . 中国专利： CN113939293A . 2022-01-14

3. COMPOSITION COMPRISING CURCUMIN-CAPTURED GINSENOSIDE AND PHOSPHOLIPID-BASED LIPID NANOPARTICLE AS EFFECTIVE INGREDIENT FOR PREVENTING OR TREATING HELICOBACTERPYLORI INFECTION [P] . 世界知识产权组织专利： WO2018135912A2 . 2018-07-26

机译：包含姜黄素捕获的人参皂苷和磷脂基脂质的组合物，是预防或治疗幽门螺杆菌 幽门螺杆菌感染的有效成分

4. COMPOSITIONS FOR PREVENTING OR TREATING OF INFECTION BY HELICOBACTER PYLORI COMPRISING CURCUMIN-ENCAPSULATED GINSENOSIDE AND PHOSPHOLIPID-BASED LIPID NANOPARTICLE [P] . 韩国专利： KR101948407B1 . 2019-02-14

机译：用于预防或治疗幽门螺杆菌的组合物，其包含姜黄素包裹的人参皂苷和磷脂基脂质体

5. COMPOSITIONS FOR PREVENTING OR TREATING OF INFECTION BY HELICOBACTER PYLORI COMPRISING CURCUMIN-ENCAPSULATED GINSENOSIDE AND PHOSPHOLIPID-BASED LIPID NANOPARTICLE [P] . 韩国专利： KR20180085947A . 2018-07-30

机译：用于预防或治疗幽门螺杆菌的组合物，其包含姜黄素包裹的人参皂苷和磷脂基脂质体

1. Is mass eradication of Helicobacter pylori infection effective for preventing gastric cancer? [Ist eine Helicobacter-pylori-Masseneradikation für die Pr?vention des Magenkarzinoms effektiv?] [J] . VeneritoM., MalfertheinerP. Zeitschrift fur Gastroenterologie . 2014,第7期

2. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China [J] . Xie Yong, Zhu Zhenhua, Wang Jiangbin, Antimicrobial agents and chemotherapy. . 2018,第9期

3. Ten-Day Quadruple Therapy Comprising Proton Pump Inhibitor, Bismuth, Tetracycline, and Levofloxacin is More Effective than Standard Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori Infection: A Randomized Controlled Trial [J] . Hsu Ping-I, Tsai Feng-Woei, Kao Sung-Shuo, The American Journal of Gastroenterology . 2017,第9期

4. Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole Bismuth Amoxicillin and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective Multicenter Randomized Parallel-Controlled Clinical Trial in China [O] . Yong Xie, Zhenhua Zhu, Jiangbin Wang, 2018

5. Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment---Helicobacter pylori positive (CADET-Hp) randomised controlled trial [O] . N. Chiba 2002

1. Impact of iHelicobacter pylori/iInfection on Serum Lipid Profile and Atherosclerosis of Carotid Artery [J] . Hadeel A. Ibrahim ,Mohammed O. Mohammed ,Hawa A. R. Dhahir . 临床医学国际期刊（英文） . 2014,第15期

2. A systematic review of treating Helicobacter pylori infection with Traditional Chinese Medicine [J] . Jiang Lin Wei-Wen Huang . 世界胃肠病学杂志：英文版 . 2009,第37期

3. 幽门螺杆菌感染和胃癌的预防与控制：中国高发区34年的实践 [C] . 游伟程 . 2018年五湖健康大会、第三届中国慢病健康管理与大健康产业峰会暨第六届西湖论健 . 2018

4. 幽门螺杆菌抗体鸡蛋制品对幽门螺杆菌感染BALB/C小鼠预防和治疗的实验研究 [A] . 韩伟平 . 2009